Medindia

X

Scientists Identify Tumor-specific Pathway, Drug Target to Halt Cancer Closer Now

by Thilaka Ravi on  November 23, 2011 at 10:07 AM Cancer News   - G J E 4
An atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer, has been identified by research team led by UT Southwestern Medical Center scientists.
Scientists Identify Tumor-specific Pathway, Drug Target to Halt Cancer Closer Now
Scientists Identify Tumor-specific Pathway, Drug Target to Halt Cancer Closer Now
Advertisement

Dr. Ralph DeBerardinis, senior author of the study published Nov. 20 in Nature, likened the newly discovered pathway to traffic that is rerouted during a highway construction project.

Advertisement
"If we hone in on this reverse pathway, then we may be able to prevent the growth of certain types of cancer," said Dr. DeBerardinis, assistant professor of pediatrics and a physician scientist in the Eugene McDermott Center for Human Growth and Development. "It's long been thought that targeting tumor-specific metabolic pathways would lead to an effective way to treat cancer. This is one of the few metabolic pathways that may actually exist specifically in tumors."

The pathway involves the Krebs cycle, a series of chemical reactions that generates energy and is considered one of the most familiar and widely studied processes in biology. In the normal cycle, energy is derived by the breakdown of acetate from ingested carbohydrates, fats and proteins into carbon dioxide and water.

For more than 70 years, biology textbooks have depicted the Krebs cycle as running clockwise in normal cells. UT Southwestern researchers found that in some tumors the cycle runs in reverse.

The discovery is the latest milestone in a long line of scientific inquiry that began in the 1920s when biochemists first recognized metabolic differences between cancer cells and normal cells. Scientists since have thought they could stop the growth of cancer cells with drugs that target only tumor-specific pathways, leaving normal cells unaffected.

Researchers have identified only a few such therapeutic windows, the latest of which appears to be the reverse Krebs cycle pathway identified by Dr. DeBerardinis and colleagues in this investigation.

"There is no pathway that has been more extensively studied over the years than the Krebs cycle," Dr. DeBerardinis said. "The fact that with relatively modest manipulation, it can run in reverse is incredibly fascinating."

Dr. James K.V. Willson, director of the Harold C. Simmons Comprehensive Cancer Center, said the findings are significant.

"We are learning that certain cancers have previously unrecognized mutations in genes controlling metabolism - and these abnormalities are providing new therapeutic opportunities," he said.



Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All